Free Review Articles on Huntington s disease                                 Metatextbook

Freie Reviews über Huntington Erkrankung                                 Look here for Journal Homepages




  • Huntington s disease
  • Wilson s disease
  • Fahr s disease
  • Tetrabenazine
  • Organelle migration
  • Autophagy
  • Trinucleotide repeat
  • Nervous system (Neurodegeneration)
  • Rapamycin
  • Proteasome
  • Heat shock response
  • HSF1
  • Hypersexuality
  • Nr.Year

    OPEN

    Titleusers

    say

    rate

    good

    rate

    bad

    no link

    Citation
    11998Treatment of the psychiatric manifestations of Huntington's disease: a review of the literature.



    +-nlCan J Psychiatry 43(9):933-40 (1998)
    21998Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association.



    +-nlJ Neuropsychiatry Clin Neurosci 10(3):249-66 (1998)
    32007Tetrabenazine in the treatment of Huntington's disease.



    +-nlNeuropsychiatr Dis Treat 3(5):545-51 (2007)
    42007Neuropsychiatry of Huntington's disease.



    +-nlDialogues Clin Neurosci 9(2):191-7 (2007)
    52005Development of novel therapies for Huntington's disease: hope and challenge.



    +-nlActa Pharmacol Sin 26(2):129-42 (2005)
    62004Huntingtin processing in pathogenesis of Huntington disease.



    +-nlActa Pharmacol Sin 25(10):1243-9 (2004)
    71999Are there multiple pathways in the pathogenesis of Huntington's disease?



    +-nlPhilos Trans R Soc Lond B Biol Sci 354(1386):995-1003 (1999)
    81982Huntington's chorea. Report of 3 cases and review of the literature.



    +-nlArch Dis Child 57(2):99-103 (1982)
    92007Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.



    +-nlArch Neurol 64(6):813-9 (2007) Ribai P
    102004Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease.



    +-nlBrain 127(Pt 6):1219-28 (2004)
    111966Huntington's chorea.



    +-nlJ Med Genet 3(4):298-314 (1966)
    122006Brain imaging and cognitive dysfunctions in Huntington's disease.



    +-nlJ Psychiatry Neurosci 31(1):21-9 (2006)
    131994Huntington's disease: pathogenesis, diagnosis and treatment.



    +-nlJ Psychiatry Neurosci 19(5):359-67 (1994)
    142006Multiple pathways contribute to the pathogenesis of Huntington disease.



    +-nlMol Neurodegener 1(-):19 (2006)
    152001Huntington's disease.



    +-nlMol Pathol 54(6):409-13 (2001)
    162004Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease.



    +-nlNeuroRx 1(2):263-72 (2004)
    172004Huntington's disease genetics.



    +-nlNeuroRx 1(2):255-62 (2004)
    182004The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.



    +-nlNeuroRx 1(1):128-38 (2004)
    191973Huntington's chorea: a centenary review.



    +-nlPostgrad Med J 49(567):32-45 (1973)
    202008Huntington disease models and human neuropathology: similarities and differences.



    +-nlActa Neuropathol 115(1):55-69 (2008)
    212010Impaired mitochondrial trafficking in Huntington's disease.



    +-nlBiochim Biophys Acta 1802(1):62-5 (2010)
    222009Mouse models of Huntington's disease and methodological considerations for therapeutic trials.



    +-nlBiochim Biophys Acta 1792(6):506-20 (2009)
    232009Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies.



    +-nlCell Death Differ 16(1):46-56 (2009)
    242008The ubiquitin-proteasome pathway in Huntington's disease.



    +-nlScientificWorldJournal 8(-):421-33 (2008)
    252011The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease.



    +-nlJ Clin Invest 121(2):476-83 (2011)
    262011Brain networks in Huntington disease.



    +-nlJ Clin Invest 121(2):484-92 (2011)
    272011Energy deficit in Huntington disease: why it matters.



    +-nlJ Clin Invest 121(2):493-9 (2011)
    282011Oligonucleotide therapeutic approaches for Huntington disease.



    +-nlJ Clin Invest 121(2):500-7 (2011)
    292011Shock and awe: unleashing the heat shock response to treat Huntington disease.



    +-nlJ Clin Invest 121(8):2972-5 (2011)
    302010Molecular mechanisms and potential therapeutical targets in Huntington's disease.



    +-nlPhysiol Rev 90(3):905-81 (2010)
    312011Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease.



    +-nlChang Gung Med J 34(2):135-52 (2011)
    322003Diagnosis of Huntington disease.



    +-nlClin Chem 49(10):1726-32 (2003)
    332010Huntington's disease: pathogenesis to animal models.



    +-nlPharmacol Rep 62(1):1-14 (2010)
    342011Hypersexual features in Huntington's disease.



    +-nlSingapore Med J 52(6):e131-3 (2011)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.